UK considers preventative drugs for breast cancer (Update)

January 15, 2013

Britain's National Health Service may soon offer women at high risk of developing breast cancer drugs normally used to treat the disease as a prevention strategy.

The National Institute for Health and Clinical Excellence on Tuesday announced draft guidelines that would make the drugs available.

A final decision is expected this spring after medical groups, charities and patients' organization respond to the proposal.

The proposal suggests that tamoxifen or raloxifene should be used by women found at high risk of developing the disease.

Clinical trials have shown the drugs can be effective in cutting breast cancer rates, and the medications are used both to treat and to prevent the disease in other countries, including the United States.

Initial response from charities and patients groups to the proposal has been favorable.

The charity Breakthrough Breast Cancer called the move "an historic step" in the fight against the deadly disease.

Specialist nurse Jackie Harris with the Breast Cancer Care charity said the proposal could be "very good news" for women with a family history of breast cancer, but doctors cautioned that the drugs cannot be viewed as a vaccine against breast cancer.

Explore further: Toxicity of aromatase inhibitors may explain lack of overall survival improvement


Related Stories

More heart problems with two chemo drugs for breast cancer

August 30, 2012

Women who have breast cancer and are treated with two chemotherapy drugs may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Health ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.